Clusterization in acute myeloid leukemia based on prognostic alternative splicing signature to reveal the clinical characteristics in the bone marrow microenvironment

Abstract

Background Alternative splicing (AS), a crucial post-transcriptional regulatory mechanism in expanding the coding capacities of genomes and increasing the diversity of proteins, still faces various challenges in the splicing regulation mechanism of acute myeloid leukemia (AML) and microenvironmental changes. Results A total of 27,833 AS events were detected in 8337 genes in 178 AML patients, with exon skip being the predominant type. Approximately 11% of the AS events were significantly related to prognosis, and the prediction models based on various events demonstrated high classification efficiencies. Splicing factors correlation networks further altered the diversity of AS events through epigenetic regulation and clarified the potential mechanism of the splicing pathway. Unsupervised cluster analysis revealed significant correlations between AS and immune features, molecular mutations, immune checkpoints and clinical outcome. The results suggested that AS clusters could be used to identify patient subgroups with different survival outcomes in AML, among which C1 was both associated with good outcome in overall survival. Interestingly, C1 was associated with lower immune scores compared with C2 and C3, and favorable-risk cytogenetics was rarely distributed in C2, but much more common in C1. Conclusions This study revealed a comprehensive landscape of AS events, and provides new insight into molecular targeted therapy and immunotherapy strategy for AML.

Expression and Regulation Network of HDAC3 in Acute Myeloid Leukemia and the Implication for Targeted Therapy Based on Multidataset Data Mining

“…Acute myeloid leukemia has become the third leading cancer threat to human health today [24][25][26]. It is characterized by the rapid proliferation of abnormal cells in the bone marrow, which affects the production of normal hematopoietic cells.…”

The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability

“…In the last few decades, epigenetic modifications (such as DNA methylation and histone modifications) have been found to play an important role in this process, and they are currently therapeutic targets in acute myeloid leukemia (AML) and other hematologic malignancies 2 . We previously reported the complex regulation of some genetic mechanisms, such as noncoding RNAs and alternative splicing in AML, and provided some insights into personalized medicine [3][4][5][6] . Currently, more in-depth investigation is essential for clarifying the pathogenesis of AML.…”

Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma

“…LUAD subtype classification based on AASEs showed distinct biological characteristics Molecular subtyping based on RNA splicing patterns has been shown to stratify patients with different prognosis or treatment efficacy in other tumor types, [30][31][32] , and thus could be leveraged to improve patient stratification in LUAD. Based on 3688 AASEs, we split 514 TCGA LUAD samples into three subtypes through consensus clustering analysis: G1 (n = 176, 34.2%), G2 (n = 130, 25.3%), and G3 (n = 208, 40.5%) (Supplementary Fig.…”